Home›Search›Diabetes Technology and Therapeutics

Diabetes Technology and Therapeutics

Mary Ann Liebert Inc. · United States · Est. 1971

ISSN1520-9156eISSN1557-8593

SJR Q1✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

2.663

H-Indexi

130

SNIPi

1.658

Total Worksi

3,872

Total Citationsi

111,143

2yr Mean Citednessi

4.29

Open Impact Factor alternative

Aims & Scope

Subject areas (NLM/MEDLINE-assigned): Blood Glucose Self-Monitoring, Diabetes Mellitus, Equipment and Supplies.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1971

FrequencyTen No. A Year, 2009-

StatusActive (last: 2026)

Total Publications3,872

Publisher OrgMary Ann Liebert, Inc.

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Mary Ann Liebert Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1520-9156 / 1557-8593

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

185

7.6k

2019

146

5.2k

2020

165

3.8k

2021

132

2.4k

2022

149

2.9k

2023

157

1.9k

2024

216

701

2025

150

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

EndocrinologyQ1

Endocrinology, Diabetes and MetabolismQ1

Medical Laboratory TechnologyQ1

Medicine (miscellaneous)Q1

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Medical Laboratory TechnologyEndocrinology, Diabetes and MetabolismEndocrinologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Diabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disordersHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and ManagementDiabetes Management and EducationDiabetes, Cardiovascular Risks, and LipoproteinsMobile Health and mHealth ApplicationsSpectroscopy Techniques in Biomedical and Chemical ResearchMetabolism, Diabetes, and Cancer

Frequently asked questions about Diabetes Technology and Therapeutics

Is Diabetes Technology and Therapeutics a predatory journal?

PubScope has no integrity flags on record for Diabetes Technology and Therapeutics: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Diabetes Technology and Therapeutics?

Diabetes Technology and Therapeutics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.29.

Is Diabetes Technology and Therapeutics indexed in Scopus and Web of Science?

Diabetes Technology and Therapeutics is indexed in Web of Science, Scopus.

What is the aims and scope of Diabetes Technology and Therapeutics?